The best selections of Biotechnology and Farma by JPMorgan for the second half
The low performance of biopharmaceutical actions versus the widest market for a third consecutive year is an opportunity for investors,…
Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals to buy 23andme and their data for $ 256 million
A view of the 23ndme headquarters in Sunnyvale, California, on March 25, 2025. Tayfun Coskun | Anadolu | Getty images…
Trump says that pharmaceutical rates are arriving, the actions fall
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters The actions of drug…
These are the top pharmaceutical stocks selected by JPMorgan for its results
JPMorgan is eyeing some drugmakers ahead of their earnings reports as investors continue to sell shares of major technology companies.…